Medicine prepared from neferine, capsaicin and 6-gingerol and used for inhibiting benign prostatic hyperplasia and application

• Main Authors: LIU QIMING, WU ZHENGPING, SHAO ZICHEN
• Format: Patent
• Language: Chinese; English
• Published: 15.02.2022
• Subjects: FOODS OR FOODSTUFFS; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES

The invention belongs to the technical field of biological medicines, and particularly relates to a medicine prepared from neensinine, capsaicin and 6-gingerol and used for inhibiting benign prostatic hyperplasia and application. The medicine for inhibiting benign prostatic hyperplasia comprises one or a combination of more of capsaicin, neferine and 6-gingerol. The capsaicin can inhibit the growth of prostate epithelial cells, various cancer cells show an anti-hyperplasia effect, the neferine can be used as a 5[alpha]-reductase to inhibit and further resist prostatic hyperplasia/hypertrophy, and the 6-gingerol is one of active ingredients extracted from the ginger, and has the pharmacological effects of resisting oxidation, reducing blood fat, diminishing inflammation and resisting hyperplasia. The medicine is used for treating prostatic diseases through pharmacology of eliminating benign prostatic hyperplasia, resisting inflammation and improving local microcirculation, and can also be used for preparing me